About Herpes
Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, treatments can help reduce the pain and decrease healing period.
TechNavio's analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Gilead Sciences
• GSK
• Merck
• Novartis
Other Prominent Vendors
• Agenus
• AiCuris
• aRigen Pharmaceuticals
• Astellas Pharma
• CytoGenix
• Epiphany Biosciences
• F. Hoffmann-La Roche
• Genocea Biosciences
• NanoBio
Market Driver
• Significant Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• Increasing Generic Competition
• For a full, detailed list, view our report
Market Trend
• Promising New Launches
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07. Competitive Assessment of Marketed Products
07.1 Five Forces Analysis
08. Rate of Incidence and Prevalence
08.1.1 US
08.1.2 UK
09. Diagnosis of Herpes
10. Market Segmentation by Product Type
11. Market Segmentation by Type of Virus
12. Market Assessment of Top Drugs
12.1 Zovirax
12.1.1 Sales
12.2 Valtrex
12.2.1 Sales
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Gilead Sciences
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2013
22.1.4 Recent Developments
22.1.5 SWOT Analysis
22.2 GlaxoSmithKline
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Pipeline Products
22.2.7 Business Strategy
22.2.8 Key Information
22.2.9 SWOT Analysis
22.3 Merck & Co. Inc.
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue 2013
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Developments
22.3.8 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
23. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Herpes Market 2013-2018 (US$ billion)
Exhibit 3: Diagnosis of Herpes
Exhibit 4: Global Herpes Market Segmentation by Type
Exhibit 5: GSK's Zovirax Revenue 2010-2013 (US$ million)
Exhibit 6: GSK's Valtrex Revenue 2010-2013 (US$ million)
Exhibit 7: Global Herpes Market by Geographical Segmentation 2013
Exhibit 8: Gilead Sciences: Geographical Segmentation by Revenue 2013
Exhibit 9: GlaxoSmithKline: Business Segmentation 2013
Exhibit 10: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 11: GlaxoSmithKline: Sales by Geography 2013
Exhibit 12: GlaxoSmithKline: Pipeline Products 2013
Exhibit 13: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 16: Novartis: Business Segmentation by Revenue 2013
Exhibit 17: Novartis: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Novartis: Sales by Geography 2013
